---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-120852"
form_type: "8-K"
ticker: "COR"
cik: "0001140859"
company_name: "Cencora, Inc."
filed_at: "2025-12-15T23:59:59+00:00"
generated_at: "2026-05-16T13:09:45.560653+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cencora acquires OneOncology majority stake for $3.6B, retires $1.3B debt; total cash ~$5.0B

## Summary
- Enterprise value $7.4B; Cencora paying $3.6B for majority equity and retiring $1.3B OneOncology debt.
- Acquisition expected to close by end of fiscal Q2 2026, subject to regulatory approvals.
- Cencora paused share repurchases; FY2026 adjusted EPS guidance reiterated but likely lower half of $17.45-$17.75.
- Long-term guidance raised: adjusted operating income growth 7-10%, adjusted EPS growth 10-14%.
- Financing via new debt; $4.5B bridge financing committed; committed to investment grade ratings.

## SEC filing metadata
- accession: 0001104659-25-120852
- form_type: 8-K
- ticker: COR
- cik: 0001140859
- company_name: Cencora, Inc.
- filed_at: 2025-12-15T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1140859/000110465925120852/0001104659-25-120852-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1140859/000110465925120852/tm2533461d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-120852
- JSON: https://secwatch.observer/filing/0001104659-25-120852.json
- Plain text: https://secwatch.observer/filing/0001104659-25-120852.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.